We’re not able to start a new treatment request while you’re already under care.
You can review your plan, request medication, or speak to your clinician in your patient portal.

Based on your assessment, we recommend the following treatments.

Daily GLP-1 treatment
Wegovy is a daily GLP-1 treatment approved for sustainable weight management, backed by robust clinical trials and trusted worldwide.


Once-weekly GLP-1 treatment
Wegovy is a once-weekly GLP-1 treatment approved for sustainable weight management, backed by robust clinical trials and trusted worldwide.
Billed every 28 days. Cancel anytime.

Once-weekly GLP-1 treatment
Originally developed for type 2 diabetes, Mounjaro is now one of the most effective GLP-1 treatments for weight loss — targeting two key hormones to deliver powerful, lasting results.
Billed every 28 days. Cancel anytime.
Place your order today
Select your treatment and complete checkout in minutes.
Doctor reviews within 24 hrs
A prescribing doctor checks your suitability and approves your order.
Delivered to your door in 2-3 days
Discreet packaging, free overnight shipping after approval.
Check-in after 4 weeks
Your prescriber reviews your progress and adjusts your dose if needed.

Once-weekly GLP-1 treatment
Wegovy is a once-weekly GLP-1 treatment approved for sustainable weight management, backed by robust clinical trials and trusted worldwide.
Billed every 28 days. Cancel anytime.

Once-weekly GLP-1 treatment
Originally developed for type 2 diabetes, Mounjaro is now one of the most effective GLP-1 treatments for weight loss — targeting two key hormones to deliver powerful, lasting results.
Billed every 28 days. Cancel anytime.

Clinically proven weight loss
We recommend Wegovy® based on your assessment. See how it works for you – no long-treatment commitment.
Love it? Your subscription continues automatically. Not for you? Cancel anytime before day 28. No fees, no hassle.
80%+ of new patients choose to continue after their first month
Cancel anytime. No long-term-commitment.

Clinically proven weight loss
We recommend Mounjaro® based on your assessment. See how it works for you – no long-treatment commitment.
Love it? Your subscription continues automatically. Not for you? Cancel anytime before day 28. No fees, no hassle.
80%+ of new patients choose to continue after their first month
Billed every 28 days. Cancel anytime.

Once-weekly GLP-1 treatment
Wegovy is a once-weekly GLP-1 treatment approved for sustainable weight management, backed by robust clinical trials and trusted worldwide.
Billed every 28 days. Cancel anytime.

Once-weekly GLP-1 treatment
Originally developed for type 2 diabetes, Mounjaro is now one of the most effective GLP-1 treatments for weight loss — targeting two key hormones to deliver powerful, lasting results.
Billed every 28 days. Cancel anytime.

Daily GLP-1 treatment
Wegovy is a daily GLP-1 treatment approved for sustainable weight management, backed by robust clinical trials and trusted worldwide.

Daily GLP-1 treatment
Wegovy is a daily GLP-1 treatmentapproved for sustainable weight management, backed by robust clinical trials and trusted worldwide.
Daily GLP-1 treatment
Wegovy is a daily GLP-1 treatment approved for sustainable weight management, backed by robust clinical trials and trusted worldwide.


Once-weekly GLP-1 treatment
Wegovy is a once-weekly GLP-1 treatment approved for sustainable weight management, backed by robust clinical trials and trusted worldwide.
Billed every 28 days. Cancel anytime.

Once-weekly GLP-1 treatment
Originally developed for type 2 diabetes, Mounjaro is now one of the most effective GLP-1 treatments for weight loss — targeting two key hormones to deliver powerful, lasting results.
Billed every 28 days. Cancel anytime.
We would like to advise that a common side effect of Mounjaro/Wegovy is modest tachycardia (increased heart rate), which may exacerbate your pre-existing condition of POTs. We can approve your treatment, providing you accept the risk of tachycardia and agree to seek urgent medical attention if you experience a persistent heart rate above 100 bpm, palpitations, chest pains, shortness of breath, or syncope.
As you start treatment with Mounjaro/Wegovy, it’s important to be aware that people with a history of bile acid malabsorption can be more sensitive to stomach-related side effects. If you notice a significant increase in diarrhoea, dehydration, dizziness, severe tummy pain, or any change that feels markedly worse than your usual symptoms, please contact your GP promptly. Make sure you stay well-hydrated, continue any prescribed treatment for BAM as directed, and let us know if you’re unable to tolerate the new medication so we can adjust the dose or review your treatment plan. Please confirm you understand and accept the above information.
Both Mounjaro/Wegovy and Alogliptin/Sitagliptin/Vildagliptin/Linagliptin act on the same hormone pathway that help control blood sugar after eating. Since Wegovy/Mounjaro already provides full, potent GLP-1 receptor stimulation, adding a DPP-4 inhibitor does not make the effect stronger. Both drugs can cause GI upset (nausea, bloating, burping), and using them together can amplify these without clinical benefit. There’s also a theoretical increase in pancreatitis risk. Patient would need to stop DPP-4 inhibitor for this reason if wanting to start mounjaro please ask them to discuss with their diabetes management team, usually GP/nurse about this change.
Before we can proceed with your order please be advised that this medication can cause gallstones and pancreatitis. Please note that even if you have had your gallbladder removed, there is still a risk that gallstones can develop in the common bile duct, which may increase the risk of pancreatitis. If you understand and accept this risk, please confirm by replying to this message, for us to proceed with your order.
We would like to advise that a common side effect of Mounjaro/Wegovy is tachycardia (increased heart rate) which may exacerbate your pre-existing condition of Atrial Fibrillation. As you have mentioned the Atrial Fibrillation is well controlled, we can approve your treatment providing you accept the risk of tachycardia and agree to seek urgent medical attention if you experience any palpitations, chest pains, shortness of breath or syncope.
No hidden costs. No guessing games.
We’re upfront because you deserve the full picture — clear pricing, proven treatments, and support that actually cares.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Satisfaction
guaranteed
Free overnight
shipping
Approval within
24 hours
*The mention of “up to 22.5% body weight loss” refers to results observed in clinical studies of Mounjaro® (tirzepatide) for weight management. The mention of "20.7%" is based on a study using Wegovy® (semaglutide) 7.2mg. Individual results may vary. Please consult your clinician to determine the most appropriate treatment for you.
Please visit the relevant website here for information about how to check the registration status of the pharmacy and the superintendent pharmacist.
Phuong Nguyen (2204151)
Bolt Healthcare Ltd
team@boltpharmacy.co.uk
Bolt Pharmacy, Unit 3C, Frontier Park, Blackburn, Lancashire, BB1 3AL
Enter your email address